Cell viability assay show that overexpression of GLT8D2 enhanced CDDP resistance compared with the vector-transfected cells, however, inhibition of GLT8D2 in ovarian cancer cells were more sensitive to CDDP treatment than control-transfected cells (Fig. 2b). This evidence concerns the gene GLT8D2 and ovarian cancer.